Rtw Investments 13F: New $55M Stake in Candel Therapeutics (CADL)
RTW Investments takes a new position in CADL, acquiring over 6.4 million shares.
Reviewed by automated data checks against the source filing. How we make and check alerts
Rtw Investments opened a new position of 6,422,018 shares in Candel Therapeutics, Inc. ($CADL), according to a 13F filing with the SEC dated May 15, 2026. It reported 6,422,018 shares worth $54.97 million at the end of the quarter.
Since the filing, $CADL is down 8.9% after 1 week, down 2.4% after 1 month and down 6.6% to date (from the $8.77 close on May 15, 2026).
CADL
Candel Therapeutics, Inc.
Key Points
- RTW Investments acquired 6,422,018 shares of CADL, valued at approximately $54.97 million, as reported in its latest 13F filing.
- Shares of CADL traded around $8.56, with recent insider purchases including significant buys by key executives.
- Analysts such as Citigroup and Canaccord Genuity maintain a 'buy' rating on CADL, with price targets as high as $26.
Get $CADL trade alerts by text
We text you when insiders, Congress or big funds trade $CADL. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Candel Therapeutics, Inc. alert may contain errors. Disclosures
RTW Investments has taken a new position in CADL, acquiring 6,422,018 shares worth around $54.97 million. This move was disclosed in the firm's latest 13F filing, which reflects holdings as of the most recent reporting period.
What Changed in RTW Investments' CADL Position
RTW Investments' latest filing reveals the fund's new acquisition of 6.42 million shares in CADL, marking a substantial new position for the firm. The shares are valued at approximately $54.97 million, with no prior holdings reported.
Other Institutional Activity in CADL
Several other institutional investors have also adjusted their positions in CADL. FMR LLC increased its holdings by 2,752,718 shares, bringing its total to 10,987,017 shares valued at about $53.84 million. Acorn Capital Advisors, LLC added 917,431 shares, ending with 3,497,948 shares worth around $17.21 million. Meanwhile, BlackRock, Inc. grew its stake by 247,353 shares, totaling 3,109,042 shares valued at approximately $15.23 million. Saturn V Capital Management LP and Portolan Capital Management, LLC both made significant additions, with Saturn V acquiring 2,896,588 shares and Portolan adding 1,198,958 shares.
Candel Therapeutics, Inc. Stock Down 21.1%
Shares of CADL recently traded around $8.56. The stock has seen varied analyst activity, with some firms maintaining a positive outlook. Despite recent market fluctuations, CADL remains an area of interest for institutional investors.
Insider Buying and Selling at Candel Therapeutics, Inc.
Insider activity at CADL includes several notable purchases. On March 31, 2026, Paul Manning purchased 4,618 shares at an average price of $4.11. Joseph Papa and Nicoletta Loggia also made smaller buys on the same date. Earlier, on February 23, 2026, Manning acquired a significant 550,458 shares at $5.45 each. Additionally, on January 26, 2026, Chief Medical Officer William Garrett Nichols and CFO Charles Schoch purchased 136,500 and 232,000 shares, respectively.
Analysts Set New Price Targets
Analyst activity for CADL has been active. On March 18, 2026, Citigroup maintained its 'buy' rating with a $26 price target. Canaccord Genuity also maintained a 'buy' rating with a $25 target on March 13, 2026. The consensus among analysts remains positive, with a mean price target reflecting optimism about CADL's future.
About CADL
CADL operates in the [sector/industry] and is involved in [brief description of what the company does]. Headquartered in [location], the company is led by CEO [CEO's name] and employs [number of employees] people.
Bottom Line
RTW Investments' new stake in CADL is a notable development, reflecting potential confidence in the company's prospects. While 13F filings are backward-looking, they provide a window into institutional sentiment. Investors often track these filings to gauge the interest of large funds and their investment strategies.
Related Filing Alerts
Source: Rtw Investments's 13F filing on $CADL (May 15, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Find the original filing: Rtw Investments 13F filings on SEC EDGAR. Written by software, not financial advice. How we make alerts